International trade policy continues to shape the economic and operational landscape of healthcare across the United States. Tariffs imposed on pharmaceuticals, active pharmaceutical ingredients (APIs), and other medical products can significantly impact supply chain costs, product availability, and formulary stability within IDNs. To combat these obstacles, pharmacy leaders must be equipped to assess how both current and future tariff structures may impact drug pricing, sourcing strategies, and care delivery.

Learning Objectives:
1. Analyze the current and emerging tariff policies impacting the availability and pricing of products.
2. Evaluate the operational obstacles posed by tariffs to procurement and inventory management.
3. Identify high-risk categories most susceptible to disruption by tariffs.
4. Formulate proactive strategies for managing financial and clinical risks associated with international trade volatility.